Comment from National Health Council

Summary: The National Health Council (NHC), an organization representing over 170 national health-related organizations and patient groups, supports the FDA's initiative to develop a regulatory framework for AI in drug and biologic development. They provide specific recommendations to ensure the framework prioritizes patient safety, transparency, rigorous validation, human oversight, and international harmonization.